Csf Contamination Check
Csf Contamination Check - Related Videos
07:45
A Cell Free Assay System Estimating the Neutralizing Capacity of GM-CSF Antibody using Recombinant Soluble GM-CSF Receptor
0 Views •
2011
We designed a cell-free receptor binding assay in order to estimate the binding of granulocyte-macrophage colony-stimulating factor (GM-CSF) to the receptors. It enables us to evaluate competitive inhibition of biotinylated GM-CSF binding to soluble GM-CSF receptor alpha by GM-CSF autoantibody with excellent reproducibility.
07:01
An In Vitro Technique to Differentiate GM-CSF Producing T Helper Cells from Naïve T Cells
0 Views •
2025
This video demonstrates the in vitro differentiation of granulocyte-macrophage-colony-stimulating factor or GM-CSF-producing T helper cells (THGM). Isolated naïve T cells are stimulated for differentiation into THGM, which is confirmed by detecting high intracellular GM-CSF production and a low expression of other T helper cell-specific cytokines.
10:21
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
0 Views •
Cited by 3 •
2018
Here detailed protocols for culturing the murine myeloid precursor 32D/G-CSF-R cell line, performing viral infections, and carrying out proliferation and differentiation assays are presented. This cell line is suitable for studying myeloid cell development, and the role of genes of interest in myeloid cell growth and neutrophilic differentiation.
01:16
Contaminants and Errors
0 Views •
2024
Effective sample preparation is crucial for accurate and reliable laboratory analysis. During this process, two significant sources of error can arise: concentration bias from improper sample splitting and contamination caused by methods used to reduce particle size, such as grinding or homogenization. Identifying and minimizing these potential errors is crucial to ensuring the validity of the analysis. Another key consideration is determining the appropriate number of samples required to...
08:40
Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure
0 Views •
Cited by 5 •
2017
A reference measurement procedure for the absolute quantification of Aβ1-42 in human CSF based on solid-phase extraction and liquid chromatography tandem mass spectrometry is described.
FAQs
An RBC pattern that decreases from earlier to later tubes is consistent with blood introduced during collection, as can occur with a traumatic tap. By contrast, persistent abnormalities across sequential tubes are more compatible with blood already present in the CSF from intracranial bleeding. The comparison therefore adds interpretive context beyond examining a single tube.
Visual appearance and red blood cell content provide related but distinct quality-control observations. Appearance can reveal that the specimen has been altered, while the cell count supplies a measurable indication of blood-related contamination. Considering both observations helps investigators judge whether an abnormal result may reflect collection quality rather than the biological condition under study.
Blood or other introduced material can affect how researchers interpret cellular and biochemical measurements in CSF. If that alteration is overlooked, downstream findings may be attributed to neurological disease rather than to collection, handling, or processing conditions. The check therefore strengthens the reliability of studies examining biomarkers, inflammation, infection, and neurological disease.
The assessment begins with inspection of the CSF sample’s appearance and evaluation of its red blood cell content. When multiple collection tubes are available, investigators compare the tubes in sequence, looking for a decline or persistence of abnormalities. They then use that pattern to interpret whether contamination likely arose during collection or reflects a more persistent abnormality.
Contamination may arise during collection, handling, or processing, so interpretation should consider the sample’s full workflow rather than the tube alone. Examining appearance and red blood cell findings in relation to the order of collection helps retain the information needed for comparison. This quality-control perspective can reduce misinterpretation of later cellular or biochemical analyses.
In neuroscience research, the check is especially relevant when CSF is used for downstream analyses of biomarkers, inflammation, infection, or neurological disease. Identifying blood-related alteration allows investigators to interpret cellular and biochemical measurements with greater caution and reliability. It also helps separate a finding associated with sample acquisition from one that may reflect the neurological process being investigated.